Australia, April 24 -- Ascendis Pharma Growth Disorders A.S, owns the trademark (2517822) for 'WELMYLI' till Oct. 25, 2034.

Status: protected: Registered/protected

Classes: 5 [Pharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasia, achondroplasia and hypochondroplasia; diagnostic preparations for medical use, namely, diagnostic preparations for identifying...